Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ)
CNY 5.67
(2.35%)
CNY 5.67
(2.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.74 Billion | 1.44 Billion | 1.44 Billion | 1.34 Billion | 1.5 Billion | 1.48 Billion |
| Cost of Revenue | 1.8 Billion | 1.43 Billion | 1.44 Billion | 1.15 Billion | 1.17 Billion | 1.12 Billion |
| Gross Profit | -63.2 Million | 9.42 Million | -4.72 Million | 184.17 Million | 334.16 Million | 360.51 Million |
| Operating Expenses | 283.46 Million | 119.28 Million | 168.71 Million | 196.45 Million | 309.67 Million | 468.3 Million |
| Selling, General and Administrative Expenses | 119.06 Million | 55.82 Million | 83.54 Million | 120.71 Million | 215.64 Million | 325.48 Million |
| Research and Development Expenses | 17.81 Million | 11.65 Million | 12.91 Million | 15.88 Million | 34.83 Million | 45.26 Million |
| Other Expenses | 91.27 Million | 51.8 Million | 72.25 Million | 59.85 Million | 59.18 Million | 97.55 Million |
| Cost and Expenses | 2.08 Billion | 1.55 Billion | 1.61 Billion | 1.35 Billion | 1.47 Billion | 1.58 Billion |
| Operating Income | -346.67 Million | -109.85 Million | -531.8 Million | 26.6 Million | 23.36 Million | -107.22 Million |
| Interest Expense | 29.68 Million | 13.55 Million | 22.59 Million | 30.82 Million | 54.13 Million | 58.95 Million |
| Income Tax Expense | -6.59 Million | 73.72 Million | -47.66 Million | -12.05 Million | -43.26 Million | -46.67 Million |
| Earnings before Tax | -354.33 Million | -246.96 Million | -538.86 Million | 2.77 Million | -559.81 Million | -921.62 Million |
| Net Income | -332.26 Million | -320.69 Million | -491.19 Million | 14.82 Million | -516.55 Million | -874.95 Million |
| Earnings Per Share Basic | -0.89 | -0.94 | -1.44 | 0.04 | -1.52 | -2.57 |
| Earnings Per Share Diluted | -0.89 | -0.94 | -1.44 | 0.04 | -1.52 | -2.57 |
| Weighted Average Shares Outstanding | 372.86 Million | 340.08 Million | 340.08 Million | 340.08 Million | 340.08 Million | 340.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 372.86 Million | 340.08 Million | 340.08 Million | 340.08 Million | 340.08 Million | 340.44 Million |
| Gross Margin | -0.04 | 0.01 | -0.00 | 0.14 | 0.22 | 0.24 |
| EBIT Margin | -0.13 | -0.05 | -0.05 | 0.11 | 0.11 | 0.04 |
| Profit Margin | -0.19 | -0.22 | -0.34 | 0.01 | -0.34 | -0.59 |
| EBITDA | -227.5 Million | -136.17 Million | -395.25 Million | 159.58 Million | -358.21 Million | -699.03 Million |
| Earnings Before Tax Margin | -0.20 | -0.08 | -0.37 | 0.02 | 0.02 | -0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 570.39 Million | 468.63 Million | 378.1 Million | 978.61 Million | 1.74 Billion | 236.49 Million |
| Cost of Revenue | 571.43 Million | 498.87 Million | 373.44 Million | 1.03 Billion | 1.77 Billion | 226.27 Million |
| Gross Profit | -1.04 Million | -30.23 Million | 4.66 Million | -55.35 Million | -35.69 Million | 10.21 Million |
| Operating Expenses | 59.55 Million | 106.15 Million | 51.13 Million | 60.2 Million | 182.29 Million | 46.19 Million |
| Selling, General and Administrative Expenses | 29.41 Million | 66.49 Million | 29.64 Million | 2.95 Million | - | 60.84 Million |
| Research and Development Expenses | 21.65 Million | 10.24 Million | 27.07 Million | 8.76 Million | - | 1.96 Million |
| Other Expenses | -8.48 Million | -29.41 Million | -6286.65 | 216.21 Thousand | -7.66 Million | -8.72 Million |
| Cost and Expenses | 630.99 Million | 605.02 Million | 424.58 Million | 1.09 Billion | 1.95 Billion | 272.46 Million |
| Operating Income | -60.59 Million | -136.39 Million | -56.63 Million | -215.04 Million | -346.67 Million | -41.25 Million |
| Interest Expense | 14.09 Million | 6.34 Million | - | 6.85 Million | 26.53 Million | - |
| Income Tax Expense | -9.17 Million | -33.96 Million | -14.15 Million | -3.07 Million | -6.59 Million | -5.95 Million |
| Earnings before Tax | -76.53 Million | -168.99 Million | -56.63 Million | -214.82 Million | -354.33 Million | -50.26 Million |
| Net Income | -45.66 Million | -108.85 Million | -30.5 Million | -196.28 Million | -332.26 Million | -44.31 Million |
| Earnings Per Share Basic | -0.13 | -0.32 | -0.08 | -0.53 | - | -0.13 |
| Earnings Per Share Diluted | -0.13 | -0.32 | -0.08 | -0.53 | - | -0.13 |
| Weighted Average Shares Outstanding | 352.92 Million | 340.08 Million | 369.81 Million | 370.17 Million | 372.86 Million | 340.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 352.92 Million | 340.08 Million | 369.81 Million | 370.17 Million | 372.86 Million | 340.08 Million |
| Gross Margin | -0.00 | -0.06 | 0.01 | -0.06 | -0.02 | 0.04 |
| EBIT Margin | -0.11 | -0.23 | -0.12 | -0.09 | - | -0.18 |
| Profit Margin | -0.08 | -0.23 | -0.08 | -0.20 | -0.19 | -0.19 |
| EBITDA | -62.44 Million | -109.35 Million | -44.71 Million | -86.88 Million | - | -41.48 Million |
| Earnings Before Tax Margin | -0.11 | -0.29 | -0.15 | -0.22 | -0.20 | -0.17 |
0L3I
YORUF
BOMBWIR
336570
LOKESHMACH
GOLKONDA